Medical/Pharmaceuticals

Skyhawk Therapeutics Presents at Huntington's Disease Youth Organization HDYO International Congress 2025

Skyhawk presents today on its novel SKY-0515 small molecule RNA splicing modulator targetingHuntington's Disease to members of the Huntington's Disease Youth Organization, at the annual HYDO International Congress inPrague, Czech Republic. BOSTON, March 15, 2025 /PRNewswire/ -- Skyhawk Therapeut...

2025-03-15 18:07 3386

Florbetaben (18F) Injection (Neuraceq®) Set to Launch at St. Teresa's Hospital in Hong Kong in March 2025

Innovative Imaging Solution to Enhance Alzheimer's Disease Diagnosis and Patient Care in the Region BOSTON, March 14, 2025 /PRNewswire/ -- Life Molecular Imaging (LMI) and St. Teresa's Hospital are pleased to announce that Florbetaben (18F) Injection (brand name: Neuraceq®) will be available in ...

2025-03-14 21:00 3948

Azurity Pharmaceuticals Completes Acquisition of Covis Pharma

WOBURN, Mass., March 14, 2025 /PRNewswire/ -- Azurity Pharmaceuticals  ("Azurity") announced today the successful completion of its acquisition of Covis Group S.à r.l. ("Covis") from existing investors. With this acquisition, Covis is now a wholly-owned subsidiary of Azurity.      This strategic ...

2025-03-14 20:52 2925

China's First IGF-1R Monoclonal Antibody: Innovent Announces NMPA approval of SYCUME® for the Treatment of Thyroid Eye Disease

SAN FRANCISCO and SUZHOU, China, March 14, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabol...

2025-03-14 16:35 4166

Teva Upgrades Its 4PL Model, Enhancing Medicine Accessibility for Patients with Kerry Pharma

HONG KONG, March 14, 2025 /PRNewswire/ -- Teva Hong Kong ("Teva"), has announced a strategic partnership with Kerry Pharma, the subsidiary of Kerry Logistics Network Ltd ("KLN"). Leveraging Kerry Pharma's extensive logistics (fourth-party logistics, 4PL) distribution capabilities, this collaborat...

2025-03-14 15:27 3426

Bowtie and Gleneagles Hospital Hong Kong Collaborate to Upgrade VHIS Rider to Include Histotripsy Treatment In "Bowtie & Gleneagles Hospital Wellness Package"

Swift inclusion of innovative liver tumor treatment technology, lowers barriers for Hongkongers to access advanced medical services HONG KONG, March 14, 2025 /PRNewswire/ -- Bowtie, Hong Kong's first virtual insurer[1], collaborates with Gleneagles Hospital Hong Kong (Gleneagles), Asia's first p...

2025-03-14 13:54 3490

VISTA Eye Specialist Enhances Cataract Surgery with Advanced Technology and Strategic Partnerships

PETALING JAYA, Malaysia, March 14, 2025 /PRNewswire/ -- Klinik Pakar Mata VISTA Eye Specialist (VISTA), awell-established name in eye care in Malaysia, continues to improve itscataract surgery services through collaborations with recognized ophthalmic technology providers such as Johnson & Johnso...

2025-03-14 08:00 2845

IFPA Forum Americas 2025: "Towards More Equitable, Person-Centered Care for All People Living with Psoriatic Disease in the Americas"

On April 4, 2025, IFPA will host the IFPA Forum 2025 for the Americas in Bogotá, Colombia. This marks the third regional forum of its kind, following successful gatherings inEurope (2022) and Asia (2023). STOCKHOLM , March 13, 2025 /PRNewswire/ -- The IFPA Forum 2025 will unite stakeholders from...

2025-03-13 17:00 2802

KLN Selected by Teva as its Exclusive 4PL Service Provider in the Greater Bay Area

HONG KONG, March 13, 2025 /PRNewswire/ -- Kerry Logistics Network Limited ('KLN'; Stock Code 0636.HK), through its subsidiary, Kerry Pharma, and Teva Pharmaceutical Hong Kong Limited ('Teva') entered into an exclusive agreement for fourth-party logistics (4PL) distribution services inHong Kong, M...

2025-03-13 16:30 2827

Caliber Launches 4 Analytics and AI-driven Solutions to Revolutionize Pharma Manufacturing and Quality

PITTSBURGH, March 13, 2025 /PRNewswire/ -- Caliber recently launched 4 digital solutions that further strengthen its portfolio and also position the company at the forefront of the Pharma 4.0 revolution. These innovations integrate AI and next-gen technologies, re...

2025-03-13 09:00 2361

Telix Adds Lead-212 Isotope Production Capability

MELBOURNE, Australia and INDIANAPOLIS, March 13, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that it has developed and validated a breakthrough generator technology for the production of lead-212 (212Pb) and successfully completed...

2025-03-13 06:48 3634

Pierre Fabre Laboratories and RedRidge Bio Announce a Drug Discovery and Co-development Partnership

CASTRES, France, CAMBRIDGE, Massachusetts and BASEL, Switzerland, March 12, 2025 /PRNewswire/ -- Pierre Fabre Laboratories and RedRidge Bio ("RedRidge") today announced an exclusive R&D collaboration and license agreement to identify and develop biparatopic antibody (BPA) drug candidates against ...

2025-03-12 17:00 2341

AIM Vaccine's Serum-Free Iterative Rabies Vaccine Has Received Production License and Will Submit for Market Registration

Launch of Major Product Expected to Significantly Drive Performance Growth HONG KONG, March 12, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement onMarch 12, 2025, the company's serum-free iterative rabies vaccine has recently obtained...

2025-03-12 07:53 2364

Ascletis Announces Positive Topline Results of Phase Ib Studies of ASC47 Monotherapy in Australia and U.S. FDA Clearance of IND Application for ASC47 in Combination with Semaglutide

* ASC47, an adipose-targeted muscle-preserving weight loss drug candidate for the treatment of obesity, demonstrated a half-life of up to 26 days and 40 days, respectively, in Phase Ib single subcutaneous injection studies in healthy subjects with elevatedlow-density lipoprotein cholesterol (LD...

2025-03-12 07:30 2714

Shilpa Medicare Secures SEC-CDSCO Nod for Nor-Ursodeoxycholic Acid Tablets, Eyes Market Launch for NASH

RAICHUR, India , March 12, 2025 /PRNewswire/ -- Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), a leading API and formulation manufacturer, announces that the Subject Expert Committee (SEC) of CDSCO has approved its Investigational New Drug (IND) – Nor Ursodeoxy...

2025-03-12 05:30 3055

TraceLink Selected as a CIOReview Top Supply Chain Solution Provider of 2025

BOSTON, March 11, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, has been recognized by CIOReview as a Top Supply Chain Solution Provider of 2025. This award highlights TraceLink's innovative approach to driving s...

2025-03-11 22:00 1921

Milliken & Company Named One of the 2025 World's Most Ethical Companies®

For the 19th consecutive year, Ethisphere recognizes manufacturer's commitment to integrity and ethical business practices SPARTANBURG, S.C., March 11, 2025 /PRNewswire/ -- Milliken & Company is honored to be included onEthisphere's 2025 World's Most Ethical Companies list for the 19th consecuti...

2025-03-11 20:05 2450

Medit Set to Launch a New Intraoral Scanner, Medit i900 classic

SEOUL, South Korea and NEWPORT BEACH, Calif., March 11, 2025 /PRNewswire/ -- Medit (www.medit.com ), a global leader in digital dentistry, is set to unveil a new addition to itsi900 intraoral scanner lineup onMarch 25. Designed to enhance usability and efficiency, the upco...

2025-03-11 15:00 3607

Gan & Lee Pharmaceuticals Announced First Participant Dosed in the US Phase 2 Clinical Study of Bofanglutide (GZR18) Injection for Overweight or Obesity

BEIJING and BRIDGEWATER, N.J., March 10, 2025 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087) announced that the first participant has been successfully dosed in a Phase 2 clinical trial of bofanglutide (research code: GZR18) injection, a bi-weekly glucagon-...

2025-03-10 23:45 2538

Sunway Medical Centre named top Malaysian Hospital in Newsweek's World's Best Hospitals ranking

SUBANG JAYA, Malaysia, March 10, 2025 /PRNewswire/ -- Sunway Medical Centre, Sunway City (SMC) has yet again ranked in the top 250 hospitals globally in the latest Newsweek's World's Best Hospitals 2025 rankings. (from left) Dato Lau Beng...

2025-03-10 21:59 3738
1 ... 65666768697071 ... 395